Complete SBFM Stock Valuation Analysis
Comprehensive intrinsic value analysis using 2 different methodologies
SBFM DCF Analysis
SBFM (Sunshine Biopharma, Inc.) discounted cash flow analysis with multiple scenarios, growth assumptions, and terminal value calculations
Financial Projections
| Metrics | 2022 (Historical) | 2023 (Historical) | 2024 (Historical) | 2025 (Projected) | 2026 (Projected) | 2027 (Projected) | 2028 (Projected) | 2029 (Projected) |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.3M | $24.1M | $34.9M | $43.6M | $54.5M | $68.1M | $85.1M | $106.4M |
| Revenue Growth % | - | 454.4% | 44.7% | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% |
| EBIT | $-8.7M | $-4.8M | $-5.8M | $2.2M | $2.7M | $3.4M | $4.3M | $5.3M |
| EBIT Margin % | -199.6% | -19.9% | -16.7% | 5.0% | 5.0% | 5.0% | 5.0% | 5.0% |
| Tax Rate % | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% |
| NOPAT | $-6.5M | $-3.6M | $-4.4M | $1.6M | $2.0M | $2.6M | $3.2M | $4.0M |
| NOPAT Margin % | -149.7% | -14.9% | -12.5% | 3.8% | 3.8% | 3.8% | 3.8% | 3.8% |
| Capex | $305.0K | $788.1K | $2.3M | $1.6M | $1.9M | $2.3M | $2.7M | $3.2M |
| Capex / Revenue % | 7.0% | 3.3% | 6.7% | 3.7% | 3.5% | 3.4% | 3.2% | 3.0% |
| Depreciation | $25.2K | $149.1K | $223.5K | $267.2K | $334.0K | $417.5K | $521.9K | $652.4K |
| D&A / Revenue % | 0.6% | 0.6% | 0.6% | 0.6% | 0.6% | 0.6% | 0.6% | 0.6% |
| Change in NWC | $18.3M | $-1.0M | $313.2K | $-498.6K | $-498.6K | $-498.6K | $-498.6K | $-498.6K |
| NWC Change / Revenue % | 420.6% | -4.3% | 0.9% | -1.1% | -0.9% | -0.7% | -0.6% | -0.5% |
| Unlevered FCF | $-25.1M | $-3.2M | $-6.8M | $777.8K | $949.1K | $1.2M | $1.5M | $1.9M |
| UFCF % Chg. | - | 87.3% | -112.6% | 111.5% | 22.0% | 24.6% | 26.6% | 28.0% |
| FCF / Revenue % | -576.7% | -13.2% | -19.4% | 1.8% | 1.7% | 1.7% | 1.8% | 1.8% |
| Discount Factor | - | - | - | 0.926 | 0.857 | 0.794 | 0.735 | 0.680 |
| Present Value of FCF | - | - | - | $720.1K | $813.5K | $938.0K | $1.1M | $1.3M |
| Sum of PV of UFCF | - | - | - | $720.1K | $1.5M | $2.5M | $3.6M | $4.9M |
WACC Calculation
Weighted Average Cost of Capital used for discounting cash flows.
| WACC Calculation | Value |
|---|---|
| Cost of Debt | 6.8% |
| Tax Rate | 25.0% |
| After Tax Cost of Debt | 5.1% |
| Risk Free Rate | 4.29% |
| Market Risk Premium | 4.3% |
| Beta | 0.96 |
| Cost of Equity | 8.4% |
| Total Debt | $952.5K |
| Market Cap | $6.5M |
| Total Capital | $7.4M |
| Debt Weighting | 12.8% |
| Equity Weighting | 87.2% |
| WACC | 8.0% |
Terminal Value
Choose between perpetuity growth or exit multiple methods.
| Terminal Value Calculation | Value |
|---|---|
| Terminal Growth Rate | 2.5% |
| Final Year FCF | $1.9M |
| Terminal Value | $35.6M |
| PV of Terminal Value | $24.2M |
| Cumulative PV of UFCF | $4.9M |
| Net Debt | $-8.7M |
| Equity Value | $37.8M |
| Shares Outstanding | 0.7M |
| Implied Share Price | $54 |
| Current Share Price | $1 |
| Implied Upside/(Downside) | +3682.3% |
Valuation Summary
$53.90
Implied Price
$1.43
Current Price
+3682.3%
Upside/Downside
8.0%
WACC
SBFM Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 6 peer companies in Healthcare
P/E Ratio
$-2.59
-281.7%
Peer Median: 0.4x
EV/EBITDA
$0.00
-100.0%
Peer Median: 0.0x
P/S Ratio
$1.43
+0.0%
Peer Median: 0.2x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for SBFM's business model and current situation.
Multiple Comparison
| Multiple | SBFM Current | Peer Median | Peer Average | Premium/Discount | Assessment |
|---|---|---|---|---|---|
| P/E Ratio | -0.2x | 0.4x | 0.4x | -155.0% | Undervalued |
| EV/EBITDA | -Infinityx | 0.0x | 0.0x | -Infinity% | Undervalued |
| P/S Ratio | 0.2x | 0.2x | 0.2x | 0.0% | Fair Value |
Peer Companies
Click any company to view their valuation
| Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
|---|---|---|---|---|
| $0.01B | 0.4x | 0.0x | 0.0x | |
| $0.01B | 0.0x | 0.0x | 495.9x | |
| $0.04B | 0.0x | 0.0x | 0.0x | |
| $0.01B | 0.0x | 0.0x | 0.2x | |
| $0.00B | 0.0x | 0.0x | 1867.7x | |
| $0.00B | 0.0x | 0.0x | 0.0x |